Chr:Pos	Ref/Alt	Identifier	Reference	Alternates	Filter	Genotypes	Read Depths (DP)	Genotype Qualities (GQ)	Alt Allele Freq	Zygosity	Genotypes	Read Depths (DP)	Genotype Qualities (GQ)	Alt Allele Freq	Zygosity	Genotypes	Read Depths (DP)	Genotype Qualities (GQ)	Alt Allele Freq	Zygosity	All MAF	Gene Names	Sequence Ontology (Combined)	Gene Region (Combined)	Effect (Combined)	Transcript Name	HGVS g.	HGVS c.	HGVS p.	Type	Protein ID	GeneID	HGNC	MIM	CCDS	HPRD	Summary of Product	Ref/Alt	Accession	1000Genomes Allele frequencies	Clinical Allele	Clinical Chanels	Clinical Significance	MedGen	SNOMED_CT	OMIM	Orphanet	GeneReviews	Disease Name	ClinVar Review Status	Gene Names	Compound Het?	Inherited From	Has Compound Het?	Inherited from Father	Inherited from Mother	In ACMG IF Genes?	In PGVD?	Ref/Alt	Classification	Notes	Gene Rank	Gene Score	Path	N of 5 Predicted Tolerated	N of 5 Predicted Damaging	SIFT Pred (C)	Polyphen2 HVAR Pred (C)	MutationTaster Pred (C)	MutationAssessor Pred (C)	FATHMM Pred (C)	VEST3 Score	VEST3 Rankscore	GERP++ NR	GERP++ RS	GERP++ RS Rankscore	PhyloP 46way Primate	PhyloP 46way Primate Rankscore	PhyloP 46way Placental	PhyloP 46way Placental Rankscore	PhyloP 100way Vertebrate	PhyloP 100way Vertebrate Rankscore	PhastCons 46way Primate	PhastCons 46way Primate Rankscore	PhastCons 46way Placental	PhastCons 46way Placental Rankscore	PhastCons 100way Vertebrate	PhastCons 100way Vertebrate Rankscore	SiPhy 29way pi	SiPhy 29way logOdds	SiPhy 29way logOdds Rankscore	LRT Omega	# Uniq RefAA/AltAA	Ref Amino Acid	Alt Amino Acid	dbSNP141 RS ID	Gene Name	CDS Strand	Ref Codon	SLR Test Statistic	Ancestral Allele	Ensembl Gene ID	Ensembl Transcript ID	SIFT Score	SIFT Converted Rankscore	SIFT Pred	Polyphen2 HDIV Score	Polyphen2 HDIV Rankscore	Polyphen2 HDIV Pred	Polyphen2 HVAR Score	Polyphen2 HVAR Rankscore	Polyphen2 HVAR Pred	LRT Score	LRT Rankscore	LRT Pred	MutationTaster Score	MutationTaster Converted Rankscore	MutationTaster Pred	MutationAssessor Score	MutationAssessor Rankscore	MutationAssessor Pred	FATHMM Score	FATHMM Rankscore	FATHMM Pred	MetaSVM Score	MetaSVM Rankscore	MetaSVM Pred	MetaLR Score	MetaLR Rankscore	MetaLR Pred	Reliability Index	Ref/Alt	HGMDID	EFFECT	MUT	PHENOTYPE	Ref/Alt	All Indiv Freq	EUR Freq	ASN Freq	AFR Freq	AMR Freq	All Indiv Major/Minor	EUR Major/Minor	ASN Major/Minor	AFR Major/Minor	AMR Major/Minor	Matched?	Name	Numbering	Date	Location	GeneSymbol	GeneStatus	Title	OMIM ID	Method	Comment	Disorders	MouseCorrelate	Reference	Morbid Description	Morbid Location	KgId	Category	In Genes?
1:2338015	T/C	rs34154371	T	C	PASS	C_T	29	99	0.52	Heterozygous	C_T	22	99	0.571429	Heterozygous	T_T	35	69	0	Reference	0.020913	PEX10	missense_variant	exon	Missense	NM_002617.3,NM_153818.1	NC_000001.10:g.2338015T>C,NC_000001.10:g.2338015T>C	NM_002617.3:c.820A>G,NM_153818.1:c.880A>G	NP_002608.1:p.Thr274Ala,NP_722540.1:p.Thr294Ala	mRNA,mRNA	NP_002608.1,NP_722540.1	5192,5192	8851,8851	602859,602859	CCDS44045.1,CCDS41.1	04175,04175	peroxisome biogenesis factor 10 isoform 2,peroxisome biogenesis factor 10 isoform 1														PEX10	False	NA	False	0	0	False	False				0.822257	0.000266419	PEX10, HP:0001939 (Abnormality of metabolism/homeostasis), HP:0003110 (Abnormality of urine homeostasis), HP:0012591 (Abnormal urinary electrolyte concentration), HP:0012607 (Abnormal urine magnesium concentration), HP:0012608 (Hypermagnesiuria)	2 of 5 Predicted as Tolerated	3 of 5 Predicted as Damaging	Tolerated	Possibly damaging	Disease causing	Predicted non-functional (neutral)	Damaging	0.151	0.18365	5.02	5.02	0.67125	0.379	0.24179	1.875	0.5433	5.632	0.67819	0.956	0.61745	0.992	0.48379	1	0.71417	0.0:0.0:0.0:1.0	13.8991	0.63792	0.146789	1	T	A		PEX10	-	ACC	-2.7586	T	ENSG00000157911	ENST00000288774,ENST00000447513,ENST00000507596	0.16	0.40728	Tolerated	0.978,0.954	0.56968	Probably damaging	0.829,0.568	0.57911	Possibly damaging	9e-06	0.64402	Deleterious	0.999	0.40733	Disease causing	-0.875	0.01424	Predicted non-functional (neutral)	-1.8,-1.8,-1.8	0.8407	Damaging	-0.3275	0.7556	Tolerated	0.1691	0.51719	Tolerated	10	T/C	CM090796	DM	T294A_Mutation	Zellweger_syndrome	T/C	0.01	0.02	0	0.0041	0.01	T/C	T/C	T/C	T/C	T/C	True	602859	1.23	01/13/09	1p36.32	PEX10, NALD	C	Peroxisome biogenesis factor 10 	602859	REc	 	Zellweger syndrome, 214100 (3); Adrenoleukodystrophy, neonatal, 202370 (3)   			Adrenoleukodystrophy, neonatal, 202370 (3)  ,Zellweger syndrome, 214100 (3)  ,	1p36.32,1p36.32,	uc001ajh.2	Morbid	False
1:43296522	G/A	rs56025238	G	A	PASS	A_G	76	99	0.493333	Heterozygous	A_G	78	99	0.421053	Heterozygous	G_G	74	99	0	Reference	0.002077	ERMAP	missense_variant	exon	Missense	NM_001017922.1,NM_018538.3	NC_000001.10:g.43296522G>A,NC_000001.10:g.43296522G>A	NM_001017922.1:c.169G>A,NM_018538.3:c.169G>A	NP_001017922.1:p.Gly57Arg,NP_061008.2:p.Gly57Arg	mRNA,mRNA	NP_001017922.1,NP_061008.2	114625,114625	15743,15743	609017,609017	CCDS475.1,CCDS475.1	12355,12355	erythroid membrane-associated protein precursor,erythroid membrane-associated protein precursor	G/A	RCV000001993.1	0.9994,0.000599	Alternate	ClinVar,OMIM Allelic Variant	Pathogenic	C0443842	115720000	111750			SCIANNA BLOOD GROUP SYSTEM, SC:-1,2	(1 Star) Classified by single submitter	ERMAP	False	NA	False	0	1	False	False				0.576507	5.5771e-05	ERMAP, GO:0005886 (plasma membrane), CASR, HP:0002150 (Hypercalciuria)	3 of 5 Predicted as Tolerated	2 of 5 Predicted as Damaging	Tolerated	Possibly damaging	Disease causing automatic	Predicted non-functional (low)	Tolerated	0.294	0.3585	4.52	1.5	0.22942	0.46	0.3903	0.133	0.18654	0.607	0.24209	0.02	0.10135	0	0.03702	0	0.05858	0.2114:0.1974:0.5912:0.0	4.0924	0.09975	1.27364	1	G	R	rs56025238	ERMAP	+	GGG		G	ENSG00000164010	ENST00000372517,ENST00000372514	0.36	0.24483	Tolerated	0.987,0.514	0.6016	Probably damaging	0.696,0.14	0.52343	Possibly damaging	0.6136	0.05809	Neutral	0	0.10124	Disease causing automatic	0.935	0.31476	Predicted non-functional (low)	1.18,1.18	0.37752	Tolerated	-1.0228	0.22034	Tolerated	0.0876	0.33818	Tolerated	9																	True	609017,111750,111620	1.324,n/a,n/a	12/28/05,?,?	1p34,n/a,n/a	ERMAP, SC, RD,n/a,n/a	C,n/a,n/a	Erythroblast membrane-associated protein , n/a, n/a	609017,n/a,n/a	REc, H, F,n/a,n/a	 , n/a, n/a	[Blood group, Scianna system], 111750 (3); [Blood group, Radin], 111620 (3)   , n/a , n/a 	4(Ermap),n/a,n/a	?,n/a,n/a	[Blood group, Radin], 111620 (3)  ,[Blood group, Scianna system], 111750 (3)  ,,n/a,n/a	1p34,1p34,,n/a,n/a	uc001cie.1,uc001cie.1,uc001cie.1	Morbid,Non-Morbid,Non-Morbid	False
2:178565913	T/C	rs17400325	T	C	PASS	C_T	29	99	0.448276	Heterozygous	C_T	27	99	0.555556	Heterozygous	C_T	36	99	0.485714	Heterozygous	0.02891	PDE11A	missense_variant	exon	Missense	NM_001077196.1,NM_016953.3,NM_001077197.1,NM_001077358.1	NC_000002.11:g.178565913T>C,NC_000002.11:g.178565913T>C,NC_000002.11:g.178565913T>C,NC_000002.11:g.178565913T>C	NM_001077196.1:c.848A>G,NM_016953.3:c.2180A>G,NM_001077197.1:c.1430A>G,NM_001077358.1:c.1106A>G	NP_001070664.1:p.Tyr283Cys,NP_058649.3:p.Tyr727Cys,NP_001070665.1:p.Tyr477Cys,NP_001070826.1:p.Tyr369Cys	mRNA,mRNA,mRNA,mRNA	NP_001070664.1,NP_058649.3,NP_001070665.1,NP_001070826.1	50940,50940,50940,50940	8773,8773,8773,8773	604961,604961,604961,604961	CCDS42786.1,CCDS33334.1,CCDS42785.1,CCDS46459.1	?,?,?,?	dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A isoform 1,dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A isoform 4,dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A isoform 3,dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A isoform 2														PDE11A	False	NA	False	0	0	False	False				0.877898	0.00034387	PDE11A, HP:0001939 (Abnormality of metabolism/homeostasis), HP:0003110 (Abnormality of urine homeostasis), HP:0012591 (Abnormal urinary electrolyte concentration), HP:0012607 (Abnormal urine magnesium concentration), HP:0012608 (Hypermagnesiuria)	0 of 5 Predicted as Tolerated	5 of 5 Predicted as Damaging	Damaging	Probably damaging	Disease causing	Predicted functional (high)	Damaging			5.7	5.7	0.88788	0.454	0.30748	2.165	0.68154	7.646	0.83445	0.824	0.46624	0.979	0.43373	1	0.71417	0.0:0.0:0.0:1.0	15.9755	0.8006		2	M,Y	V,C	rs17400325,rs17400325	PDE11A,PDE11A	-,-	ATG,TAT	?,?	T,T	ENSG00000128655,ENSG00000128655	ENST00000433879,ENST00000286063,ENST00000358450,ENST00000409504,ENST00000389683,ENST00000449286	0	?,0.87932	?,Damaging	1,1	?,0.89917	?,Probably damaging	0.961,0.995	?,0.81914	?,Probably damaging	?,0	?,0.85682	?,Deleterious	1,1	0.70825,0.70825	Disease causing,Disease causing	3.635,3.635	0.95187,0.95187	Predicted functional (high),Predicted functional (high)	-2.31,-2.31,-2.31,-2.31,-2.31	?,0.87887	?,Damaging	0.1158,0.1158	0.85446,0.85446	Damaging,Damaging	0.4271,0.4271	0.78362,0.78362	Tolerated,Tolerated	5,10	T/C	CM094021	DM?	Y727C_Mutation	Adrenocortical_tumours	T/C	0.03	0.06	0	0.0041	0.05	T/C	T/C	T/C	T/C	T/C	True	610475,604961	n/a,2.529	?,03/08/07	n/a,2q31.2	n/a,PDE11A, PDE11A1, PDE11A2, PDE11A3, PPNAD2	n/a,P	 n/a,Phosphodiesterase 11A 	n/a,604961	n/a,REc, Fd	 n/a, 	 n/a ,Pigmented nodular adrenocortical disease, primary, 2, 610475 (3)    	n/a,?	n/a,?	n/a,Pigmented nodular adrenocortical disease, primary, 2, 610475 (3)  	n/a,2q31.2	uc002ulq.2,uc002ulq.2	Non-Morbid,Morbid	False
3:15686693	G/C	rs13078881	G	C	PASS	C_G	48	99	0.395833	Heterozygous	G_G	32	69	0	Reference	C_G	35	99	0.485714	Heterozygous	0.030063	BTD	missense_variant	exon	Missense	NM_000060.2	NC_000003.11:g.15686693G>C	NM_000060.2:c.1330G>C	NP_000051.1:p.Asp444His	mRNA	NP_000051.1	686	1122	609019	CCDS2628.1	08359	biotinidase precursor	G/C,G/C,G/C,G/C,G/C,G/C,G/C	RCV000001977.1,RCV000001981.1,RCV000021912.1,RCV000021933.1,RCV000021936.2,RCV000021952.1,RCV000078064.1	0.9814,0.01857,0.9814,0.01857,0.9814,0.01857,0.9814,0.01857,0.9814,0.01857,0.9814,0.01857,0.9814,0.01857	Alternate,Alternate,Alternate,Alternate,Alternate,Alternate,Alternate	ARUP BTD,ClinVar,Emory University,GeneReviews,OMIM Allelic Variant,OMIM Allelic Variant,ARUP BTD,ClinVar,Emory University,GeneReviews,OMIM Allelic Variant,OMIM Allelic Variant,ARUP BTD,ClinVar,Emory University,GeneReviews,OMIM Allelic Variant,OMIM Allelic Variant,ARUP BTD,ClinVar,Emory University,GeneReviews,OMIM Allelic Variant,OMIM Allelic Variant,ARUP BTD,ClinVar,Emory University,GeneReviews,OMIM Allelic Variant,OMIM Allelic Variant,ARUP BTD,ClinVar,Emory University,GeneReviews,OMIM Allelic Variant,OMIM Allelic Variant,ARUP BTD,ClinVar,Emory University,GeneReviews,OMIM Allelic Variant,OMIM Allelic Variant	Pathogenic,Pathogenic,Pathogenic,Pathogenic,Pathogenic,Pathogenic,Pathogenic	C0220754,C0220754,C0220754,C0220754,C0220754,C0220754,CN221809	8808004,8808004,8808004,8808004,8808004,8808004,?	253260,253260,253260,253260,253260,253260,?	79241,79241,79241,79241,79241,79241,?	NBK1322,NBK1322,NBK1322,NBK1322,NBK1322,NBK1322,?	Biotinidase deficiency,Biotinidase deficiency,Biotinidase deficiency,Biotinidase deficiency,Biotinidase deficiency,Biotinidase deficiency,not provided	(2 Stars) Classified by multiple submitters,(2 Stars) Classified by multiple submitters,(1 Star) Classified by single submitter,(1 Star) Classified by single submitter,(2 Stars) Classified by multiple submitters,(1 Star) Classified by single submitter,(1 Star) Classified by single submitter	BTD	False	NA	False	0	0	False	False				0.8949	0.000349218	BTD, HP:0003110 (Abnormality of urine homeostasis), HP:0012591 (Abnormal urinary electrolyte concentration), HP:0012607 (Abnormal urine magnesium concentration), HP:0012608 (Hypermagnesiuria)	0 of 5 Predicted as Tolerated	5 of 5 Predicted as Damaging	Damaging	Probably damaging	Disease causing automatic	Predicted functional (medium)	Damaging	0.817	0.8067	5.58	3.8	0.43715	-0.224	0.1242	0.743	0.32719	3.159	0.50731	0.979	0.70002	0.092	0.20876	1	0.71417	0.1379:0.0:0.8621:0.0	12.205	0.54346	0.392353	1	D	H	rs13078881	BTD	+	GAT	-18.0305	G	ENSG00000169814	ENST00000449107,ENST00000303498,ENST00000437172,ENST00000383778	0	0.87932	Damaging	1,1,1	0.89917	Probably damaging	0.987,0.987,0.987	0.76071	Probably damaging	0.011652	0.29616	Neutral	0.992	0.37049	Disease causing automatic	2.99	0.88906	Predicted functional (medium)	-3.72,-3.72,-3.72,-3.72	0.95482	Damaging	0.4644	0.90733	Damaging	0.7567	0.92331	Damaging	9	G/C	CM980257	DM	D444H_Mutation	Biotinidase_deficiency\x2c_partial	G/C	0.02	0.04	0	0.002	0.02	G/C	G/C	G/C	G/C	G/C	True	609019	3.40	11/29/04	3p25	BTD	P	Biotinidase 	609019	A	 	Biotinidase deficiency, 253260 (3)    			Biotinidase deficiency, 253260 (3)  	3p25	uc003cah.2	Morbid	False
6:6167822	C/T	rs138754417	C	T	PASS	C_T	19	99	0.421053	Heterozygous	C_C	18	33	0.0555556	Reference	C_T	9	32	0.666667	Heterozygous	0.002691	F13A1	missense_variant	exon	Missense	NM_000129.3	NC_000006.11:g.6167822C>T	NM_000129.3:c.1777G>A	NP_000120.2:p.Gly593Ser	mRNA	NP_000120.2	2162	3531	134570	CCDS4496.1		coagulation factor XIII A chain precursor														F13A1	False	NA	False	1	0	False	False				0.162287	2.61799e-06	F13A1, GO:0007596 (blood coagulation), EGF, HP:0002917 (Hypomagnesemia)	3 of 5 Predicted as Tolerated	2 of 5 Predicted as Damaging	Tolerated	Benign	Polymorphism	Predicted functional (medium)	Damaging	0.642	0.6607	5.54	-0.331	0.12679	-0.35	0.07774	-0.396	0.07703	-0.19	0.09615	0.046	0.14306	0.014	0.15608	0	0.05858	0.0:0.4166:0.1124:0.471	7.2104	0.25931	0.421727	1	G	S	rs138754417	F13A1	-	GGC		C	ENSG00000124491	ENST00000264870,ENST00000441301	0.67	0.10902	Tolerated	0.018,0.015	0.16603	Benign	0.002,0.011	0.14578	Benign	0.02121	0.27043	Neutral	1	0.10124	Polymorphism	2.08	0.68317	Predicted functional (medium)	-2.12	0.86432	Damaging	-0.8042	0.56056	Tolerated	0.2678	0.65302	Tolerated	10	C/T	CM103182	DM	G593S_Mutation	Factor_XIII_deficiency	C/T	0.0014	0.004	0	0	0	C/T	C/T	C/T	C/T	C/T	True	134570	6.31	06/04/90	6p25-p24	F13A1, F13A	C	Coagulation factor XIII, A polypeptide 	134570	F, Fd, A, D	 	Factor XIIIA deficiency (3)    			Factor XIIIA deficiency (3)  	6p25-p24	uc003mwv.2	Morbid	False
6:51889483	G/A	rs45517932	G	A	PASS	A_G	84	99	0.464286	Heterozygous	G_G	82	99	0	Reference	A_G	81	99	0.3875	Heterozygous	0.003998	PKHD1	missense_variant	exon	Missense	NM_138694.3,NM_170724.2	NC_000006.11:g.51889483G>A,NC_000006.11:g.51889483G>A	NM_138694.3:c.5125C>T,NM_170724.2:c.5125C>T	NP_619639.3:p.Leu1709Phe,NP_733842.2:p.Leu1709Phe	mRNA,mRNA	NP_619639.3,NP_733842.2	5314,5314	9016,9016	606702,606702	CCDS4935.1,CCDS4936.1	?,?	fibrocystin isoform 1 precursor,fibrocystin isoform 2 precursor														PKHD1	False	NA	False	1	0	False	False				0.826893	0.000266609	PKHD1, HP:0001939 (Abnormality of metabolism/homeostasis), HP:0003110 (Abnormality of urine homeostasis), HP:0012591 (Abnormal urinary electrolyte concentration), HP:0012607 (Abnormal urine magnesium concentration), HP:0012608 (Hypermagnesiuria)	1 of 5 Predicted as Tolerated	4 of 5 Predicted as Damaging	Tolerated	Probably damaging	Disease causing	Predicted functional (medium)	Damaging	0.749	0.74635	5.55	4.68	0.58851	0.65	0.86243	1.353	0.45828	6.432	0.734	0.132	0.20833	0.57	0.28473	1	0.71417	0.0751:0.0:0.9249:0.0	13.5415	0.61676	0.082046	1	L	F	rs45517932	PKHD1	-	CTT		G	ENSG00000170927	ENST00000371117,ENST00000340994,ENST00000393616	0.2	0.36615	Tolerated	0.997,1	0.89917	Probably damaging	0.994,0.997	0.8513	Probably damaging	7.7e-05	0.52532	Deleterious	0.714	0.30663	Disease causing	2.045	0.66939	Predicted functional (medium)	-2.14,-2.33	0.88046	Damaging	0.3511	0.89133	Damaging	0.6735	0.89508	Damaging	10	G/A	CM034269	DM	L1709F_Mutation	Polycystic_kidney_disease	G/A	0.0014	0	0	0	0.01	G/A	G/A	G/A	G/A	G/A	True	606702	6.367	02/26/02	6p21.1-p12	FCYT, PKHD1, ARPKD	C	Fibrocystin 	606702	Fd, H	 	Polycystic kidney and hepatic disease, 263200 (3)    	13(Pkhd1)		Polycystic kidney and hepatic disease, 263200 (3)  	6p21.1-p12	uc003pah.1	Morbid	False
8:21981218	C/T	rs117197822	C	T	PASS	C_T	12	99	0.416667	Heterozygous	C_C	23	48	0	Reference	C_T	9	85	0.333333	Heterozygous	0.019723	HR	missense_variant	exon	Missense	NM_018411.4,NM_005144.4	NC_000008.10:g.21981218C>T,NC_000008.10:g.21981218C>T	NM_018411.4:c.1859G>A,NM_005144.4:c.1859G>A	NP_060881.2:p.Arg620Gln,NP_005135.2:p.Arg620Gln	mRNA,mRNA	NP_060881.2,NP_005135.2	55806,55806	5172,5172	602302,602302	CCDS6023.1,CCDS6022.1	03808,03808	protein hairless isoform b,protein hairless isoform a														HR	False	NA	False	0	0	False	False				0.837713	0.000268816	HR, HP:0001939 (Abnormality of metabolism/homeostasis), HP:0003110 (Abnormality of urine homeostasis), HP:0012591 (Abnormal urinary electrolyte concentration), HP:0012607 (Abnormal urine magnesium concentration), HP:0012608 (Hypermagnesiuria)	2 of 5 Predicted as Tolerated	3 of 5 Predicted as Damaging	Tolerated	Probably damaging	Disease causing	Predicted functional (medium)	Tolerated	0.33	0.39591	5.05	5.05	0.67936	0.313	0.20887	2.493	0.84123	1.699	0.37804	0.618	0.37518	1	0.80357	1	0.71417	0.0:1.0:0.0:0.0	14.2578	0.66062	0	1	R	Q	rs117197822	HR	-	CGG	-31.0313	C	ENSG00000168453	ENST00000381418,ENST00000312841	0.17	0.39692	Tolerated	1,1	0.89917	Probably damaging	0.996,0.992	0.83275	Probably damaging	0.000155	0.49305	Deleterious	0.585	0.29744	Disease causing	2.075	0.67953	Predicted functional (medium)	-0.58,-0.6	0.71817	Tolerated	-0.1628	0.79852	Tolerated	0.2522	0.6357	Tolerated	10	C/T	CM980996	DM?	R620Q_Mutation	Congenital_atrichia	C/T	0.01	0.02	0	0.002	0.01	C/T	C/T	C/T	C/T	C/T	True	602302,209500,203655	8.86,n/a,n/a	07/20/09,?,?	8p21.2,n/a,n/a	HR, AU, MUHH1,n/a,n/a	C,n/a,n/a	Hairless, mouse, homolog of , n/a, n/a	602302,n/a,n/a	H, R, Fd, LD,n/a,n/a	 , n/a, n/a	Alopecia universalis, 203655 (3); Atrichia with papular lesions, 209500 (3); Hypotrichosis, hereditary, Marie Unna type, 1, 146550 (3)   , n/a , n/a 	14(hr),n/a,n/a	?,n/a,n/a	Alopecia universalis, 203655 (3)  ,Atrichia with papular lesions, 209500 (3)  ,Hypotrichosis, hereditary, Marie Unna type, 1, 146550 (3)  ,,n/a,n/a	8p21.2,8p21.2,8p21.2,,n/a,n/a	uc003xas.2,uc003xas.2,uc003xas.2	Morbid,Non-Morbid,Non-Morbid	False
10:115348046	G/A	rs7080536	G	A	PASS	A_G	51	99	0.510204	Heterozygous	G_G	50	93	0	Reference	A_G	58	99	0.561404	Heterozygous	0.02791	HABP2	missense_variant	exon	Missense	NM_001177660.1,NM_004132.3	NC_000010.10:g.115348046G>A,NC_000010.10:g.115348046G>A	NM_001177660.1:c.1523G>A,NM_004132.3:c.1601G>A	NP_001171131.1:p.Gly508Glu,NP_004123.1:p.Gly534Glu	mRNA,mRNA	NP_001171131.1,NP_004123.1	3026,3026	4798,4798	603924,603924	CCDS53579.1,CCDS7577.1	04890,04890	hyaluronan-binding protein 2 isoform 2,hyaluronan-binding protein 2 isoform 1 preproprotein	G/A,G/A,G/A	RCV000006338.1,RCV000006339.1,RCV000006340.1	0.9918,0.008187,0.9918,0.008187,0.9918,0.008187	Alternate,Alternate,Alternate	ClinVar,OMIM Allelic Variant,ClinVar,OMIM Allelic Variant,ClinVar,OMIM Allelic Variant	Pathogenic,other,other	CN068943,C1858964,C1858964	?,?,?	?,?,?	?,?,?	?,?,?	Factor VII Marburg I Variant Thrombophilia,Carotid stenosis, susceptibility to,Venous thromboembolism, susceptibility to	(1 Star) Classified by single submitter,(1 Star) Classified by single submitter,(1 Star) Classified by single submitter	HABP2	False	NA	False	0	0	False	False				0.349304	6.15766e-06	HABP2, GO:0007155 (cell adhesion), ARVCF, HP:0002901 (Hypocalcemia)	0 of 5 Predicted as Tolerated	5 of 5 Predicted as Damaging	Damaging	Probably damaging	Disease causing	Predicted functional (medium)	Damaging	0.846	0.8345	5.93	5.93	0.9592	0.561	0.74099	2.815	0.96918	7.569	0.8238	0.1	0.18952	1	0.80357	1	0.71417	0.0:0.0:1.0:0.0	20.3437	0.98782	0	1	G	E	rs7080536	HABP2	+	GGG		G	ENSG00000148702	ENST00000542051,ENST00000351270	0	0.87932	Damaging	1	0.89917	Probably damaging	1	0.9711	Probably damaging	0	0.85682	Deleterious	1	0.70825	Disease causing	2.335	0.76433	Predicted functional (medium)	-3.4,-3.4	0.9433	Damaging	0.3902	0.89697	Damaging	0.6823	0.89812	Damaging	10	G/A	CM032937	DFP	G534E_Mutation	Carotid_stenosis\x2c_association_with	G/A	0.01	0.03	0	0	0.02	G/A	G/A	G/A	G/A	G/A	True	603924	10.375	04/17/06	10q25-q26	HABP2, PHBP, HGFAL, FSAP	P	Hyaluronan-binding protein 2 	603924	A	 	{Carotid stenosis, susceptibility to} (3); {Venous thromboembolism, susceptibility to}, 188050 (3)   			{Carotid stenosis, susceptibility to} (3)  ,{Venous thromboembolism, susceptibility to}, 188050 (3)  ,	10q25-q26,10q25-q26,	uc010qry.1,uc001lai.3,	Morbid	False
11:67250676	G/A	rs145047094	G	A	PASS	A_G	87	99	0.413793	Heterozygous	A_G	88	99	0.363636	Heterozygous	G_G	96	99	0	Reference	0.00254	AIP	missense_variant	exon	Missense	NM_003977.2	NC_000011.9:g.67250676G>A	NM_003977.2:c.47G>A	NP_003968.2:p.Arg16His	mRNA	NP_003968.2	9049	358	605555	CCDS8168.1		AH receptor-interacting protein	G/A	RCV000034083.2	0.9994,0.000599	Alternate	ClinVar,GeneReviews	Uncertain Significance	C0346302	254957009	102200	963	NBK97965	Somatotroph adenoma	(1 Star) Classified by single submitter	AIP	False	NA	False	0	0	False	False				0.942813	0.000397268	AIP, HP:0010929 (Abnormality of cation homeostasis), HP:0010927 (Abnormality of divalent inorganic cation homeostasis), HP:0004921 (Abnormality of magnesium homeostasis), HP:0002917 (Hypomagnesemia)	2 of 5 Predicted as Tolerated	3 of 5 Predicted as Damaging	Damaging	Benign	Disease causing	Predicted non-functional (low)	Damaging	0.806	0.79654	5.69	3.81	0.43845	0.462	0.41574	1.397	0.46682	1.684	0.37649	0.732	0.41865	1	0.80357	1	0.71417	0.1873:0.0:0.8127:0.0	7.5963	0.2805	0.196016	1	R	H	rs145047094	AIP	+	CGT	-11.2382	G	ENSG00000110711	ENST00000528641,ENST00000279146,ENST00000529797	0.02	0.66056	Damaging	0.969	0.54964	Probably damaging	0.416	0.43331	Benign	0.000469	0.44285	Deleterious	0.999	0.40733	Disease causing	1.795	0.58101	Predicted non-functional (low)	-2.9,-2.9,-2.9	0.9174	Damaging	0.2861	0.88167	Damaging	0.6611	0.89072	Damaging	10	G/A	CM071540	DM?	R16H_Mutation	Pituitary_adenoma	G/A	0.0009	0.0026	0	0	0	G/A	G/A	G/A	G/A	G/A	True	605555,219090,102200	11.475,n/a,n/a	04/01/08,?,?	11q13.3,n/a,n/a	AIP, XAP2, ARA9,n/a,n/a	P,n/a,n/a	Aryl hydrocarbon receptor-interacting protein , n/a, n/a	605555,n/a,n/a	REa, A,n/a,n/a	 , n/a, n/a	Pituitary adenoma, growth hormone-secreting, 102200 (3); Pituitary adenoma, prolactin-secreting, 600634 (3); Pituitary adenoma, ACTH-secreting, 219090 (3)  , n/a , n/a 	?,n/a,n/a	?,n/a,n/a	Pituitary adenoma, ACTH-secreting, 219090 (3)  ,Pituitary adenoma, growth hormone-secreting, 102200 (3)  ,Pituitary adenoma, prolactin-secreting, 600634 (3)  ,,n/a,n/a	11q13.3,11q13.3,11q13.3,,n/a,n/a	uc001olv.2,uc001olv.2,uc001olv.2,uc002xzw.2,	Morbid,Non-Morbid,Non-Morbid	False
12:57424918	G/A	rs113470661	G	A	PASS	A_G	45	99	0.577778	Heterozygous	G_G	36	72	0	Reference	A_G	40	99	0.473684	Heterozygous	0.005228	MYO1A	missense_variant	exon	Missense	NM_005379.3,NM_001256041.1	NC_000012.11:g.57424918G>A,NC_000012.11:g.57424918G>A	NM_005379.3:c.2390C>T,NM_001256041.1:c.2390C>T	NP_005370.1:p.Ser797Phe,NP_001242970.1:p.Ser797Phe	mRNA,mRNA	NP_005370.1,NP_001242970.1	4640,4640	7595,7595	601478,601478	CCDS8929.1,CCDS8929.1	?,?	unconventional myosin-Ia,unconventional myosin-Ia														MYO1A	False	NA	False	1	0	False	False				0.358578	6.35023e-06	MYO1A, GO:0009925 (basal plasma membrane), GO:0016020 (membrane), SLC12A1, HP:0002150 (Hypercalciuria)	1 of 5 Predicted as Tolerated	4 of 5 Predicted as Damaging	Damaging	Benign	Disease causing	Predicted functional (medium)	Damaging	0.783	0.77583	4.23	4.23	0.50019	0.563	0.77884	2.066	0.61787	8.155	0.89643	0.806	0.45545	0.065	0.19835	1	0.71417	0.0:0.0:1.0:0.0	12.4785	0.55829	0.205104	1	S	F	rs113470661	MYO1A	-	TCC		G	ENSG00000166866	ENST00000300119,ENST00000442789,ENST00000544473	0.01	0.72032	Damaging	0.437	0.34103	Benign	0.201	0.35353	Benign	0.000661	0.42682	Deleterious	0.958	0.34273	Disease causing	2.16	0.71036	Predicted functional (medium)	-2.25,-2.25,-2.31	0.87887	Damaging	0.1897	0.86649	Damaging	0.499	0.82222	Tolerated	10	G/A	CM031291	DM	S797F_Mutation	Sensorineural_deafness\x2c_nonsyndromic	G/A	0.0027	0.01	0	0	0	G/A	G/A	G/A	G/A	G/A	True	607841,601478	n/a,12.322	?,01/11/07	n/a,12q13-q15	n/a,MYO1A, DFNA48	n/a,C	 n/a,Myosin IA 	n/a,601478	n/a,A, Fd	 n/a, 	 n/a ,Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)    	n/a,10(Myo1a)	n/a,?	n/a,Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)  	n/a,12q13-q15	uc001smw.3,uc001smw.3	Non-Morbid,Morbid	False
12:103246701	A/G	rs76212747	A	G	PASS	A_G	73	99	0.549296	Heterozygous	A_G	65	99	0.492063	Heterozygous	A_A	65	99	0	Reference	0.000538	PAH	missense_variant	exon	Missense	NM_000277.1	NC_000012.11:g.103246701A>G	NM_000277.1:c.734T>C	NP_000268.1:p.Val245Ala	mRNA	NP_000268.1	5053	8582	612349	CCDS9092.1	08943	phenylalanine-4-hydroxylase	A/G,A/G,A/G	RCV000000664.1,RCV000089065.1,RCV000148724.1	0.9996,0.9996,0.9996	Alternate,Alternate,Alternate	ClinVar,DeBelle Laboratory for Biochemical Genetics,OMIM Allelic Variant,University of Washington,ClinVar,DeBelle Laboratory for Biochemical Genetics,OMIM Allelic Variant,University of Washington,ClinVar,DeBelle Laboratory for Biochemical Genetics,OMIM Allelic Variant,University of Washington	Pathogenic,Not Provided,Uncertain Significance	C0751435,CN221809,CN221596	?,?,?	?,?,?	?,?,?	?,?,?	Hyperphenylalaninemia, non-pku,not provided,Hyperphenylalaninaemia	(1 Star) Classified by single submitter,(0 Stars) Not classified by submitter,(1 Star) Classified by single submitter	PAH	False	NA	False	0	0	False	False				0.8949	0.000349218	PAH, HP:0003110 (Abnormality of urine homeostasis), HP:0012591 (Abnormal urinary electrolyte concentration), HP:0012607 (Abnormal urine magnesium concentration), HP:0012608 (Hypermagnesiuria)	1 of 5 Predicted as Tolerated	4 of 5 Predicted as Damaging	Tolerated	Probably damaging	Disease causing automatic	Predicted functional (medium)	Damaging	0.944	0.93948	5.92	5.92	0.9559	0.455	0.32223	2.266	0.75297	9.339	0.96797	0.997	0.91878	1	0.80357	1	0.71417	1.0:0.0:0.0:0.0	16.3594	0.83251	0.053982	1	V	A		PAH	-	GTG	-21.5776	A	ENSG00000171759	ENST00000553106,ENST00000307000	0.22	0.34782	Tolerated	1	0.89917	Probably damaging	0.999	0.91635	Probably damaging	1e-06	0.64402	Neutral	1	0.70825	Disease causing automatic	2.28	0.74881	Predicted functional (medium)	-6.69,-6.69	0.99766	Damaging	1.0692	0.98681	Damaging	0.9883	0.99691	Damaging	9	A/G	CM941133	DM	V245A_Mutation	Hyperphenylalaninaemia												True	612349,261600	12.528,n/a	03/24/09,?	12q24.1,n/a	PAH, PKU1,n/a	C,n/a	Phenylalanine hydroxylase , n/a	612349,n/a	REa, A, Fd,n/a	close to IGF1 , n/a	Phenylketonuria, 261600 (3); [Hyperphenylalaninemia, non-PKU mild], 261600 (3)   , n/a 	10(Pah),n/a	?,n/a	Phenylketonuria, 261600 (3)  ,[Hyperphenylalaninemia, non-PKU mild], 261600 (3)  ,,n/a	12q24.1,12q24.1,,n/a	uc001tjq.1,uc001tjq.1	Morbid,Non-Morbid	False
12:109683531	A/G	rs147443159	A	G	PASS	A_G	57	99	0.428571	Heterozygous	A_G	57	99	0.454545	Heterozygous	A_A	44	90	0	Reference	0.000615	ACACB	missense_variant	exon	Missense	NM_001093.3	NC_000012.11:g.109683531A>G	NM_001093.3:c.5279A>G	NP_001084.3:p.Asn1760Ser	mRNA	NP_001084.3	32	85	601557	CCDS31898.1		acetyl-CoA carboxylase 2 precursor														ACACB	False	NA	False	0	1	False	False				0.497682	1.6114e-05	ACACB, GO:0012505 (endomembrane system), GO:0044464 (cell part), GO:0005575 (cellular_component), TBL2, HP:0002150 (Hypercalciuria)	2 of 5 Predicted as Tolerated	3 of 5 Predicted as Damaging	Tolerated	Probably damaging	Disease causing	Predicted non-functional (low)	Damaging	0.274	0.33696	4.9	4.9	0.64082	0.26	0.18958	1.975	0.57531	8.773	0.91762	0.983	0.724	1	0.80357	1	0.71417	1.0:0.0:0.0:0.0	14.8397	0.70214	0.098929	1	N	S	rs147443159	ACACB	+	AAC		A	ENSG00000076555	ENST00000338432,ENST00000377848,ENST00000377854,ENST00000390027,ENST00000543201,ENST00000537347	0.38	0.23302	Tolerated	0.997	0.69078	Probably damaging	0.968	0.70227	Probably damaging	1e-06	0.64402	Deleterious	1	0.70825	Disease causing	1.045	0.35249	Predicted non-functional (low)	-3.69,-3.69,-3.68,-3.57	0.95377	Damaging	0.7284	0.94011	Damaging	0.8521	0.95446	Damaging	10	A/G	CM137594	DM?	N1760S_Mutation	Hyperinsulinism	A/G	0.0018	0.004	0	0.002	0	A/G	A/G	A/G	A/G	A/G	True	601557	12.521	06/09/98	12q24.1	ACACB, ACCB, ACC2	P	Acetyl-Coenzyme A carboxylase, beta 	601557	A	 	    			n/a	n/a	uc001toc.2	Non-Morbid	False
15:48500263	G/A	rs34819316	G	A	PASS	A_G	162	99	0.552795	Heterozygous	A_G	199	99	0.507692	Heterozygous	G_G	200	99	0.005	Reference	0.004003	SLC12A1	missense_variant	exon	Missense	NM_000338.2,NM_001184832.1	NC_000015.9:g.48500263G>A,NC_000015.9:g.48500263G>A	NM_000338.2:c.347G>A,NM_001184832.1:c.347G>A	NP_000329.2:p.Arg116His,NP_001171761.1:p.Arg116His	mRNA,mRNA	NP_000329.2,NP_001171761.1	6557,6557	10910,10910	600839,600839	CCDS10129.2,CCDS53940.1	?,?	solute carrier family 12 member 1 isoform A,solute carrier family 12 member 1 isoform F														SLC12A1	False	NA	False	0	1	False	False				0.998454	0.00142176	SLC12A1, HP:0002150 (Hypercalciuria)	0 of 5 Predicted as Tolerated	5 of 5 Predicted as Damaging	Damaging	Possibly damaging	Disease causing	Predicted functional (medium)	Damaging	0.951	0.9477	5.58	5.58	0.84498	0.655	0.94253	2.624	0.88883	9.869	0.9981	0.993	0.82548	1	0.80357	1	0.71417	0.0:0.0:1.0:0.0	19.5825	0.95473	0	1	R	H	rs34819316	SLC12A1	+	CGT		G	ENSG00000074803	ENST00000380993,ENST00000396577,ENST00000330289	0.05	0.56958	Damaging	0.881,0.994	0.6483	Probably damaging	0.48,0.828	0.57846	Possibly damaging	0	0.85682	Deleterious	1	0.70825	Disease causing	2.24	0.73598	Predicted functional (medium)	-4.22,-4.22,-4.22	0.97041	Damaging	0.8835	0.95804	Damaging	0.9083	0.97195	Damaging	10	G/A	CM108770	DM	R116H_Mutation	Bartter_syndrome	G/A	0.0005	0.0013	0	0	0	G/A	G/A	G/A	G/A	G/A	True	601678,600839	n/a,15.98	?,08/23/04	n/a,15q15-q21.1	n/a,SLC12A1, NKCC2	n/a,C	 n/a,Solute carrier family 12 (sodium/potassium/chloride transporters), member 1	n/a,600839	n/a,H, Fd, LD	 n/a, 	 n/a ,Bartter syndrome, type 1, 601678 (3)    	n/a,2(Slc12a1)	n/a,?	n/a,Bartter syndrome, type 1, 601678 (3)  	n/a,15q15-q21.1	uc001zwn.3,uc001zwn.3	Non-Morbid,Morbid	False
17:41246812	A/C	rs28897675	A	C	PASS	A_C	191	99	0.5	Heterozygous	A_A	191	99	0.00537634	Reference	A_C	195	99	0.455497	Heterozygous	0.000231	BRCA1	missense_variant	exon	Missense	NM_007298.3,NM_007297.3,NM_007299.3,NM_007300.3,NM_007294.3	NC_000017.10:g.41246812A>C,NC_000017.10:g.41246812A>C,NC_000017.10:g.41246812A>C,NC_000017.10:g.41246812A>C,NC_000017.10:g.41246812A>C	NM_007298.3:c.736T>G,NM_007297.3:c.595T>G,NM_007299.3:c.736T>G,NM_007300.3:c.736T>G,NM_007294.3:c.736T>G	NP_009229.2:p.Leu246Val,NP_009228.2:p.Leu199Val,NP_009230.2:p.Leu246Val,NP_009231.2:p.Leu246Val,NP_009225.1:p.Leu246Val	mRNA,mRNA,mRNA,mRNA,mRNA	NP_009229.2,NP_009228.2,NP_009230.2,NP_009231.2,NP_009225.1	672,672,672,672,672	1100,1100,1100,1100,1100	113705,113705,113705,113705,113705	CCDS11454.2,CCDS11459.2,CCDS11455.2,CCDS11456.2,CCDS11453.1	?,?,?,?,?	breast cancer type 1 susceptibility protein isoform 4,breast cancer type 1 susceptibility protein isoform 3,breast cancer type 1 susceptibility protein isoform 5,breast cancer type 1 susceptibility protein isoform 2,breast cancer type 1 susceptibility protein isoform 1	A/C,A/C,A/C,A/C,A/C	RCV000034762.2,RCV000049113.3,RCV000112779.1,RCV000148400.1,RCV000148401.1	0.9998,0.0001997,0.9998,0.0001997,0.9998,0.0001997,0.9998,0.0001997,0.9998,0.0001997	Alternate,Alternate,Alternate,Alternate,Alternate	ClinVar,ClinVar,GeneDx,University of Washington,ClinVar,ClinVar,GeneDx,University of Washington,ClinVar,ClinVar,GeneDx,University of Washington,ClinVar,ClinVar,GeneDx,University of Washington,ClinVar,ClinVar,GeneDx,University of Washington	other,Benign,Uncertain Significance,Uncertain Significance,Uncertain Significance	CN221809,C0677776,C2676676,CN221562,CN221572	?,?,?,?,?	?,?,604370,?,?	?,?,145,?,?	?,NBK1247,NBK1247,?,?	not provided,BRCA1 and BRCA2 Hereditary Breast and Ovarian Cancer,Breast-ovarian cancer, familial 1,Breast and/or ovarian cancer,Breast cancer	(2 Stars) Classified by multiple submitters,(1 Star) Classified by single submitter,(1 Star) Classified by single submitter,(1 Star) Classified by single submitter,(1 Star) Classified by single submitter	BRCA1	False	NA	False	0	0	True	False				0.633694	9.84582e-05	BRCA1, HP:0000119 (Abnormality of the genitourinary system), HP:0000079 (Abnormality of the urinary system), HP:0011277 (Abnormality of the urinary system physiology), HP:0003110 (Abnormality of urine homeostasis), HP:0012591 (Abnormal urinary electrolyte concentration), HP:0012607 (Abnormal urine magnesium concentration), HP:0012608 (Hypermagnesiuria)	2 of 5 Predicted as Tolerated	3 of 5 Predicted as Damaging	Tolerated	Probably damaging	Disease causing	Predicted non-functional (low)	Damaging			4.64	2.26	0.28386	0.482	0.46254	0.918	0.36919	-0.451	0.06795	0.144	0.21451	0.998	0.56505	0	0.05858	0.4766:0.2924:0.0936:0.1374	2.0172	0.035		2	I,L	M,V		BRCA1,BRCA1	-,-	ATT,TTG	?,?	A,A	ENSG00000012048,ENSG00000012048	ENST00000473961,ENST00000357654,ENST00000412061,ENST00000354071,ENST00000346315,ENST00000468300,ENST00000393691,ENST00000471181,ENST00000493795,ENST00000491747,ENST00000478531,ENST00000484087,ENST00000493919,ENST00000487825,ENST00000470026,ENST00000477152,ENST00000494123	0.27	?,0.30854	?,Tolerated	0.996,0.7,0.982,0.816,0.816,0.816,0.99,0.982,0.997,1,0.998	?,0.89917	?,Probably damaging	0.82,0.132,0.952,0.232,0.232,0.232,0.961,0.952,0.991,0.981,0.996	?,0.83275	?,Probably damaging	?,0.010268	?,0.30159	?,Neutral	0.999,0.999	0.40733,0.40733	Disease causing,Disease causing	1.645,1.645	0.52364,0.52364	Predicted non-functional (low),Predicted non-functional (low)	-2.24,-2.35,-2.34,-2.17,-2.64,-2.24,-2.36,-2.02,-2.06,-2.26,-1.89,-2.79,-4.23,-2.48	?,0.97066	?,Damaging	0.6576,0.6576	0.93183,0.93183	Damaging,Damaging	0.881,0.881	0.96352,0.96352	Damaging,Damaging	5,10	A/C,A/C	CM045534,CS042532	DM?,DM	L246V_Mutation,736TtoG_Splice	Breast_and/or_ovarian_cancer,Breast_cancer	A/C	0.0005	0.0013	0	0	0	A/C	A/C	A/C	A/C	A/C	True	113705	17.351	02/17/09	17q21	BRCA1, PSCP, BROVCA1	C	Breast cancer-1 gene 	113705	Fd, REc	 	{Breast-ovarian cancer, familial, 1}, 604370 (3)    	11(Brca1)		{Breast-ovarian cancer, familial, 1}, 604370 (3)  	17q21	uc002ict.2	Morbid	False
18:55226380	C/T	rs118204037	C	T	PASS	C_T	125	99	0.447154	Heterozygous	C_T	127	99	0.472	Heterozygous	C_C	157	99	0	Reference	0.001	FECH	missense_variant	exon	Missense	NM_000140.3,NM_001012515.2	NC_000018.9:g.55226380C>T,NC_000018.9:g.55226380C>T	NM_000140.3:c.801G>A,NM_001012515.2:c.819G>A	NP_000131.2:p.Met267Ile,NP_001012533.1:p.Met273Ile	mRNA,mRNA	NP_000131.2,NP_001012533.1	2235,2235	3647,3647	612386,612386	CCDS11964.1,CCDS32836.1	01509,01509	ferrochelatase, mitochondrial isoform b precursor,ferrochelatase, mitochondrial isoform a precursor	C/T	RCV000000579.1	0.9992,0,0,0.0007987	Alternate	ClinVar,OMIM Allelic Variant	Pathogenic	C0162568	51022005	177000	79278	NBK100826	Erythropoietic protoporphyria	(1 Star) Classified by single submitter	FECH	False	NA	False	0	0	False	False				0.822257	0.000266419	FECH, HP:0001939 (Abnormality of metabolism/homeostasis), HP:0003110 (Abnormality of urine homeostasis), HP:0012591 (Abnormal urinary electrolyte concentration), HP:0012607 (Abnormal urine magnesium concentration), HP:0012608 (Hypermagnesiuria)	1 of 5 Predicted as Tolerated	4 of 5 Predicted as Damaging	Tolerated	Possibly damaging	Disease causing	Predicted functional (medium)	Damaging	0.854	0.84243	4.82	4.82	0.62117	0.655	0.94253	2.646	0.89796	5.38	0.66202	0.865	0.49528	1	0.80357	1	0.71417	0.0:1.0:0.0:0.0	18.0542	0.89358	0.038851	1	M	I	rs118204037	FECH	-	ATG	-30.6283	C	ENSG00000066926	ENST00000262093,ENST00000382873	0.08	0.51188	Tolerated	0.876,0.85	0.46327	Possibly damaging	0.687,0.559	0.51999	Possibly damaging	0	0.85682	Deleterious	1	0.70825	Disease causing	2.61	0.82823	Predicted functional (medium)	-4.19,-4.19	0.96967	Damaging	1.0094	0.97554	Damaging	0.915	0.97402	Damaging	10	C/T	CM910156	DM	M267I_Mutation	Protoporphyria\x2c_erythropoietic	C/T	0.0005	0.0013	0	0	0	C/T	C/T	C/T	C/T	C/T	True	612386	18.139	11/07/08	18q21.3	FECH, FCE	C	Ferrochelatase 	612386	A, REb	 	Protoporphyria, erythropoietic, autosomal dominant, 177000 (3); Protoporphyria, erythropoietic, autosomal recessive, 177000 (3)   			Protoporphyria, erythropoietic, autosomal dominant, 177000 (3)  ,Protoporphyria, erythropoietic, autosomal recessive, 177000 (3)  ,	18q21.3,18q21.3,	uc002lgp.3	Morbid	False
21:43809092	C/T	rs45598239	C	T	PASS	C_T	40	99	0.540541	Heterozygous	C_C	28	48	0	Reference	C_T	30	99	0.533333	Heterozygous	0.034984	TMPRSS3	missense_variant	exon	Missense	NM_032404.2,NM_001256317.1,NM_024022.2,NM_032405.1	NC_000021.8:g.43809092C>T,NC_000021.8:g.43809092C>T,NC_000021.8:g.43809092C>T,NC_000021.8:g.43809092C>T	NM_032404.2:c.-114G>A,NM_001256317.1:c.268G>A,NM_024022.2:c.268G>A,NM_032405.1:c.268G>A	?,NP_001243246.1:p.Ala90Thr,NP_076927.1:p.Ala90Thr,NP_115781.1:p.Ala90Thr	mRNA,mRNA,mRNA,mRNA	NP_115780.1,NP_001243246.1,NP_076927.1,NP_115781.1	64699,64699,64699,64699	11877,11877,11877,11877	605511,605511,605511,605511	?,CCDS58790.1,CCDS13686.1,CCDS42939.1	?,?,?,?	transmembrane protease serine 3 isoform 2,transmembrane protease serine 3 isoform 4,transmembrane protease serine 3 isoform 1,transmembrane protease serine 3 isoform 3	C/T	RCV000039344.1	0.9898,0.01018	Alternate	ClinVar,ClinVar,ClinVar	Benign	CN169374					not specified	(1 Star) Classified by single submitter	TMPRSS3	False	NA	False	0	0	False	False				0.474498	1.22401e-05	TMPRSS3, GO:0005789 (endoplasmic reticulum membrane), CFTR, HP:0002150 (Hypercalciuria)	0 of 5 Predicted as Tolerated	4 of 5 Predicted as Damaging		Possibly damaging	Disease causing	Predicted functional (medium)	Damaging	0.39	0.454	5.23	5.23	0.7285	0.561	0.74099	2.443	0.82685	4.157	0.58144	0.008	0.0643	0.079	0.20413	0.992	0.36948	0.0:1.0:0.0:0.0	18.8283	0.92127	0.138905	1	A	T	rs45598239	TMPRSS3	-	GCT		C	ENSG00000160183	ENST00000291532,ENST00000433957,ENST00000398405,ENST00000380399,ENST00000398397				0.967,0.977,0.96	0.56746	Probably damaging	0.765,0.787,0.816	0.57244	Possibly damaging	0.000189	0.48286	Deleterious	0.953	0.3408	Disease causing	2.3	0.75447	Predicted functional (medium)	-3.7,-3.7,-3.7,-3.7,-3.7	0.95412	Damaging	0.2534	0.8766	Damaging	0.62	0.87529	Damaging	9	C/T	CM054156	DM?	A90T_Mutation	Deafness\x2c_childhood_onset	C/T	0.02	0.04	0	0.0041	0.02	C/T	C/T	C/T	C/T	C/T	True	605511	21.131	01/08/01	21q22.3	TMPRSS3, ECHOS1, DFNB8, DFNB10	C	Transmembrane protease, serine 3 	605511	Fd, REc	 	Deafness, autosomal recessive 8, childhood onset, 601072 (3); Deafness, autosomal recessive 10, congenital, 605316 (3)   			Deafness, autosomal recessive 10, congenital, 605316 (3)  ,Deafness, autosomal recessive 8, childhood onset, 601072 (3)  ,	21q22.3,21q22.3,	uc002zbb.2	Morbid	False
22:37333657	C/A	rs1801122	C	A	PASS	A_C	23	99	0.652174	Heterozygous	C_C	27	60	0	Reference	A_C	25	99	0.6	Heterozygous	0.025895	CSF2RB	missense_variant	exon	Missense	NM_000395.2	NC_000022.10:g.37333657C>A	NM_000395.2:c.1807C>A	NP_000386.1:p.Pro603Thr	mRNA	NP_000386.1	1439	2436	138981	CCDS13936.1	00739	cytokine receptor common subunit beta precursor														CSF2RB	False	NA	False	0	0	False	False				0.576507	5.5771e-05	CSF2RB, GO:0005886 (plasma membrane), CASR, HP:0002150 (Hypercalciuria)	0 of 5 Predicted as Tolerated	5 of 5 Predicted as Damaging	Damaging	Probably damaging	Disease causing	Predicted functional (medium)	Damaging	0.4	0.46318	5.36	5.36	0.76844	0.557	0.71058	2.51	0.84645	0.984	0.29565	0.02	0.10135	1	0.80357	0.997	0.39634	0.0:1.0:0.0:0.0	14.5889	0.68347	1.22227	1	P	T	rs1801122	CSF2RB	+	CCT	-7.907	C	ENSG00000100368	ENST00000403662,ENST00000539104,ENST00000262825,ENST00000406230,ENST00000536485	0.03	0.62326	Damaging	1,1	0.89917	Probably damaging	0.973,0.956	0.71414	Probably damaging	0.649172	0.06009	Neutral	0.933	0.33464	Disease causing	2.24	0.73598	Predicted functional (medium)	-4.01,-4.55,-4.55,-4.56	0.97831	Damaging	0.4224	0.90156	Damaging	0.8476	0.95303	Damaging	10	C/A	CM970401	DM?	P603T_Mutation	Pulmonary_alveolar_proteinosis	C/A	0.01	0.03	0	0.01	0.01	C/A	C/A	C/A	C/A	C/A	True	265120,138981	n/a,22.183	?,04/16/07	n/a,22q12.2-q13.1	n/a,CSF2RB	n/a,P	 n/a,Colony-stimulating factor-2 receptor, beta, low-affinity 	n/a,138981	n/a,Psh, A	 n/a, 	 n/a ,    	n/a,?	n/a,?	n/a,n/a	n/a,n/a	uc003aqa.3,uc002sqh.2,,uc003aqa.3	Non-Morbid,Non-Morbid	False
X:100653420	C/A	rs28935490	C	A	PASS	A_A	25	51	1	Homozygous Variant	A_A	46	87	1	Homozygous Variant	C_C	18	33	0	Reference	0.002935	RPL36A-HNRNPH2,GLA	missense_variant	exon	Missense	NM_001199974.1,NM_001199973.1,NM_000169.2	NC_000023.10:g.100653420C>A,NC_000023.10:g.100653420C>A,NC_000023.10:g.100653420C>A	NM_001199974.1:c.285+6610C>A,NM_001199973.1:c.408+2975C>A,NM_000169.2:c.937G>T	?,?,NP_000160.1:p.Asp313Tyr	mRNA,mRNA,mRNA	NP_001186903.1,NP_001186902.1,NP_000160.1	100529097,100529097,2717	48349,48349,4296	?,?,300644	?,?,CCDS14484.1	?,?,02357	RPL36A-HNRNPH2 protein isoform b,RPL36A-HNRNPH2 protein isoform a,alpha-galactosidase A precursor	C/A,C/A,C/A	RCV000011486.2,RCV000029944.1,RCV000035314.1		Alternate,Alternate,Alternate	ClinVar,ClinVar,LabCorp,OMIM Allelic Variant,ClinVar,ClinVar,LabCorp,OMIM Allelic Variant,ClinVar,ClinVar,LabCorp,OMIM Allelic Variant	Uncertain Significance,Likely Pathogenic,Likely Benign	C0002986,C0949658,CN169374	16652001,83978005,?	301500,192600,?	324,99739,?	NBK1292,NBK1768,?	Fabry's disease,Primary familial hypertrophic cardiomyopathy,not specified	(1 Star) Classified by single submitter,(1 Star) Classified by single submitter,(1 Star) Classified by single submitter	GLA,RPL36A-HNRNPH2	False	NA	False,False	0,0	0,0	True,False	False				0.913447,0.0819165	0.000353856,1.6663e-06	GLA, HP:0003110 (Abnormality of urine homeostasis), HP:0012591 (Abnormal urinary electrolyte concentration), HP:0012607 (Abnormal urine magnesium concentration), HP:0012608 (Hypermagnesiuria),RPL36A-HNRNPH2, GO:0005840 (ribosome), GO:0030529 (ribonucleoprotein complex), GO:0032991 (macromolecular complex), GO:0005575 (cellular_component), TBL2, HP:0002150 (Hypercalciuria)	0 of 5 Predicted as Tolerated	4 of 5 Predicted as Damaging	Damaging	Possibly damaging	Disease causing		Damaging	0.545	0.5853	5.79	-5.05	0.02955	-0.217	0.12591	-1.018	0.03363	0.137	0.15995	0.844	0.47949	0.055	0.19348	0.979	0.34478	0.0:0.2038:0.0967:0.6995	10.2254	0.43222	0.330516	1	D	Y		GLA	-	GAT	-1.1927	C	ENSG00000102393	ENST00000218516	0	0.87932	Damaging	0.999	0.76494	Probably damaging	0.89	0.61533	Possibly damaging	0.0014	0.39341	Neutral	0.756	0.31014	Disease causing				-8.15	0.9993	Damaging	1.0972	0.99577	Damaging	0.9927	0.9984	Damaging	9	C/A	CM930335	DM?	D313Y_Mutation	Fabry_disease	C/A	0.0012	0.0017	0	0	0.0036	C/A	C/A	C/A	C/A	C/A	True	300644	23.384	03/28/07	Xq22	GLA	C	Galactosidase, alpha 	300644	S, R, A, Fd	 	Fabry disease, 301500 (3); Fabry disease, cardiac variant, 301500 (3)    	X(Ags)		Fabry disease, 301500 (3)  ,Fabry disease, cardiac variant, 301500 (3)  ,	Xq22,Xq22,	uc004ehl.1	Morbid	False
